share_log

Jefferies Downgrades BELLUS Health to Hold, Lowers Price Target to $14.75

Benzinga ·  Apr 19, 2023 09:17

Jefferies analyst Suji Jeong downgrades BELLUS Health (NASDAQ:BLU) from Buy to Hold and lowers the price target from $21 to $14.75.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment